News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies
A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer…